patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Manolo - you may already know this but...
Pluristem will not automatically be listed on the NASDAQ.  Pluristem must first meet specfic requirement in order to be listed.  I believe one of the requirements is to maintain a share price at or above $5.00 for specified length of time and at the time of the actual listing.  I also think there is a specified amount of income a company must earn in order to be listed.

Nov 27, 2007 11:17AM
Share
New Message
Please login to post a reply